Ventana Medical Systems
Xiaoling Xia currently serves as a Principal Scientist at Roche Tissue Diagnostics (Ventana Medical Systems), a position held since January 2022. Before this role, Xia held the title of Senior Scientist at Ventana Medical Systems from May 2011, contributing to the organization for over a decade. Previous experience includes serving as a Senior Research Associate at Genentech from August 2007 to April 2011, and a Senior Associate Biologist at Eli Lilly and Company from 1998 to 2007, showcasing a robust background in scientific research and development within the biotechnology industry.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.